Motagon is the cannabis subsidiary of international Czech
pharmaceutical company, Heaton AS, and a joint venture with
Jelinda (Germany) and KOMAND Consulting (Canada).
Our mission is to guarantee that the optimal
cannabis-based medicine is made available to
all patients that can benefit from the qualities
of the cannabis plant.
Motagon accesses Heaton’s global sales
and distribution network.
We source and contract manufacture effective cannabis-based pharmaceuticals from around the globe, including Spain, Portugal,and Canada.
LICENSES AND CERTIFICATIONS
EU manufactured cannabis flowers in following concentrations
EU manufactured full-spectrum extracts
Advanced product forms
Expertise from leading global markets
We use our proprietary artificial intelligence technologies to process large amounts of real world data and help physicians make informed decisions that best serve their patients and improve health outcomes.
Jaromir Fric jr.
Director, Corporate Development
Head of QA, QP
Regulatory Affairs Manager
Head of Logistics
Motagon partners up with Medisonal to revamp the medical cannabis education system in the Czech Republic
November 2nd, 2022, Prague – Motagon, a pharmaceutical company based in Prague and specialising in medical cannabis, has entered into a strategic...
Motagon has been issued by the State Institute for Drug Control (SUKL) a certificate of EU-GMP compliance of a manufacturer for active substances....
MOTAGON to become the first pharmaceutical company in the Czech Republic to supply medical cannabis extracts to patients
August 11, 2022, Prague – MOTAGON, a pharmaceutical company based in Prague and specializing in medical cannabis, has secured a ground-breaking...